HK Stock MarketDetailed Quotes
06600 SCICLONE PHARMA
- 18.000
- -0.040-0.22%
Market Closed Apr 19 16:08 CST
11.30BMarket Cap9.13P/E (TTM)
18.100High17.960Low3.38MVolume18.100Open18.040Pre Close60.75MTurnover0.54%Turnover Ratio9.13P/E (Static)627.65MShares18.28052wk High3.14P/B11.30BFloat Cap8.75052wk Low0.38Dividend TTM627.65MShs Float18.640Historical High--Dividend LFY0.78%Amplitude5.260Historical Low17.991Avg Price500Lot Size2.13%Div YieldTTM--Div Yield LFY
SCICLONE PHARMA Key Stats
EPS
According to the latest financial report of SCICLONE PHARMA, the latest earnings per share (TTM) for the company is 1.90. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: HKD
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out SCICLONE PHARMA's latest financial report to see how much their book value per share (BVPS) is currently at 5.75.
Currency: HKD
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of SCICLONE PHARMA shows that the company's current ratio is 4.94, indicating healthy liquidity.
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of SCICLONE PHARMA, the quick ratio is 4.50, indicating that the company can meet its short-term debt obligations.
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of SCICLONE PHARMA? The latest ROE figure is 35.54%, indicating that the company has stable profitability.
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of SCICLONE PHARMA, the total asset return on investment (ROA) is 26.70%.
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check SCICLONE PHARMA's latest financial report to see how their gross margin is doing - currently at 74.67%.
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of SCICLONE PHARMA, the net profit margin is 35.55%, which is a good sign for its profitability.
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg